Diadia
Our TechnologyResearchResourcesAboutLoginBook a call

© 2026 Diadia. All rights reserved.

About UsOur TechnologyResearchResourcesResearch
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions
About UsOur TechnologyResearchResourcesResearch
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions

© 2026 Diadia. All rights reserved.

←Transparency Reports

metabolic · Mechanism Report

Does the MTHFR 677TT genotype reduce folate-dependent homocysteine metabolism and raise homocysteine?

Two copies of MTHFR C677T reduce enzyme activity and are associated with higher homocysteine, especially when folate status is low.

PlausibleOctober 2, 20269 Sources

Reasoning Paths

Each route from condition to outcome carries a support score — the product of its edge weights. Select one to isolate it on the figure.

This is what AI claimed

Two copies of MTHFR C677T reduce MTHFR enzyme activity and can impair folate-dependent homocysteine metabolism, increasing the likelihood of elevated homocysteine, especially when folate status is low.

laying out figure…
3 of 4 paths supported
UnsupportedPlausibleSupported

How to read the figure

Evidence state

  • ●EstablishedStrong, replicated evidence.
  • ◐ModerateEvidence-informed; limited or moderate.
  • ◇PlausibleMechanistically coherent, not established.
  • ✕UnsupportedTested and not supported — link breaks.
  • ?MissingNo evidence either way — untested.

Node shapes

  • BiomarkerA measurable state — a lab value, hormone, or genetic factor.
  • ProcessA biological process, pathway, or mechanism step.
  • ConditionA condition, exposure, intervention, or symptom.
  • OutcomeThe endpoint the claim leads to.

Executive summary

The claim says the 677TT genotype lowers MTHFR activity, which can limit folate-dependent remethylation of homocysteine. The mechanism framing matches a shift toward higher circulating homocysteine when folate availability is reduced. It also indicates that the genotype effect is stronger in low-folate states and smaller when folate status is higher.

Verified conclusion

The claim is well supported: MTHFR 677TT (two C677T copies) is a common functional genotype that reduces enzyme activity and, particularly in lower-folate states, shifts folate-dependent homocysteine handling toward higher circulating homocysteine.

Functional and clinical-biochemical evidence

  • The Ala222Val enzyme encoded by 677TT is thermolabile and has substantially reduced activity in human lymphocyte and fibroblast experiments—often about 30% of 677CC activity, although the magnitude varies by tissue, temperature, and cofactor conditions.
  • Meta-analytic data show TT carriers have, on average, plasma total homocysteine about 2.7 μmol/L higher and serum folate about 2.5 nmol/L lower than CT/CC groups.
  • In a controlled feeding study, homocysteine rose more in TT than CC men; 79% versus 7%, respectively, exceeded 14 μmol/L by study end.

Mechanism and folate dependence

  • MTHFR generates 5-methyltetrahydrofolate, required by vitamin B12-dependent methionine synthase to remethylate homocysteine to methionine. Reduced MTHFR function therefore constrains this folate-dependent pathway, rather than directly impairing methionine synthase.
  • Human lymphoblast isotope-tracer studies demonstrate reduced folate-dependent remethylation in TT cells under folate restriction. TT is also associated with lower serum/plasma and red-cell folate measures.
  • The genotype effect on homocysteine is strongest at low folate status and is attenuated or no longer significant with higher folate or folic-acid supplementation; TT individuals may nonetheless show a smaller serum-folate increase after supplementation.

Clinical implications

  • Bottom line: 677TT increases population-level susceptibility to elevated homocysteine, especially with low folate, but does not diagnose hyperhomocysteinemia or determine an individual’s cause. When clinically relevant, assess total homocysteine alongside folate and vitamin B12; methylmalonic acid can help clarify suspected B12 deficiency.

References

  1. Molecular Biology of Methylenetetrahydrofolate Reductase (MTHFR ... — ncbi.nlm.nih.gov ↗
  2. Methylenetetrahydrofolate reductase and psychiatric diseases — pmc.ncbi.nlm.nih.gov ↗
  3. 5,10-Methylenetetrahydrofolate Reductase (MTHFR) Assay in the Forward Direction: Residual Activity in MTHFR Deficiency — academic.oup.com ↗
  4. Folate restriction and methylenetetrahydrofolate reductase 677T polymorphism decreases adoMet synthesis via folate-dependent remethylation in human-transformed lymphoblasts - PubMed — pubmed.ncbi.nlm.nih.gov ↗
  5. The impact of MTHFR 677 C/T genotypes on folate status ... — pubmed.ncbi.nlm.nih.gov ↗
  6. a systematic review and meta-analysis of trials and ... — pubmed.ncbi.nlm.nih.gov ↗
  7. Folate Intake at RDA Levels Is Inadequate for Mexican American ... — pmc.ncbi.nlm.nih.gov ↗
  8. Common Methylenetetrahydrofolate Reductase Gene Mutation Leads to Hyperhomocysteinemia but Not to Vascular Disease | Circulation — ahajournals.org ↗
  9. Interactions between lifestyle and MTHFR polymorphisms on homocysteine concentrations in young adults belonging to the 1982 Pelotas Birth Cohort - European Journal of Clinical Nutrition — nature.com ↗

See a full patient report verified like this

Book a walkthrough

Related Claims

Plausible9 sourcesIs the APOA5 rs662799 C allele linked to higher triglycerides and lower HDL cholesterol?→Supported5 sourcesIs serum magnesium an imperfect marker of total-body magnesium status?→